Literature DB >> 4038606

Anticardiolipin antibodies in autoimmune thrombocytopenic purpura.

E N Harris, A E Gharavi, U Hegde, G Derue, S H Morgan, H Englert, J K Chan, R A Asherson, G R Hughes.   

Abstract

Using a recently devised solid phase radioimmunoassay to detect anticardiolipin antibodies, we report the presence of these antibodies in 30 of 96 patients with chronic autoimmune thrombocytopenic purpura (AITP). IgG anticardiolipin antibody levels were elevated in 14 patients and IgM anticardiolipin antibody levels were elevated in 27 patients. We suggest that these antibodies may mediate peripheral platelet destruction by binding to phospholipids in the platelet membrane. It is also conceivable that the presence of anticardiolipin antibodies may select a subpopulation of patients with chronic AITP who may go on to develop other autoimmune disorders, such as systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4038606     DOI: 10.1111/j.1365-2141.1985.tb02989.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  30 in total

1.  Severe thrombocytopenia secondary to asymptomatic cytomegalovirus infection in an immunocompetent host.

Authors:  J G Wright
Journal:  J Clin Pathol       Date:  1992-11       Impact factor: 3.411

2.  Anti-phospholipid antibodies bind to platelet microparticles in idiopathic (autoimmune) thrombocytopenic purpura.

Authors:  S Nomura; M Yanabu; T Fukuroi; H Kido; T Kawakatsu; K Yamaguchi; M Suzuki; T Kokawa; K Yasunaga
Journal:  Ann Hematol       Date:  1992-07       Impact factor: 3.673

3.  Relationship of microparticles with beta 2-glycoprotein I and P-selectin positivity to anticardiolipin antibodies in immune thrombocytopenic purpura.

Authors:  S Nomura; M Yanabu; T Miyake; Y Miyazaki; H Kido; H Kagawa; S Fukuhara; Y Komiyama; E Matsuura; T Koike
Journal:  Ann Hematol       Date:  1995-01       Impact factor: 3.673

4.  Antiplatelet glycoprotein autoantibodies in patients with autoimmune diseases with and without thrombocytopenia.

Authors:  I Cordiano; F Salvan; M L Randi; M A Ruffatti; A Steffan; A Girolami; F Fabris
Journal:  J Clin Immunol       Date:  1996-11       Impact factor: 8.317

Review 5.  Antiphospholipid antibody syndrome: a review.

Authors:  P J Bingley; B I Hoffbrand
Journal:  J R Soc Med       Date:  1987-07       Impact factor: 5.344

Review 6.  Diagnosis and management of patients with the antiphospholipid syndrome.

Authors:  B M Alving
Journal:  J Thromb Thrombolysis       Date:  2001-09       Impact factor: 2.300

7.  Management of myocardial infarction in immune thrombocytopenic purpura with anti-phospholipid antibodies.

Authors:  Rie Tabata; Chiharu Tabata; Yoshio Kita
Journal:  J Thromb Thrombolysis       Date:  2013-01       Impact factor: 2.300

8.  The serology and immunochemistry of HIV-induced platelet-bound immunoglobulin.

Authors:  R J Klaassen; J van der Lelie; A B Vlekke; H M Weigel; J K Eeftinck Schattenkerk; P Reiss; A E von dem Borne
Journal:  Blut       Date:  1989-07

9.  The specificity of anti-cardiolipin antibodies from syphilis patients and from patients with systemic lupus erythematosus.

Authors:  S Mouritsen; M Høier-Madsen; A Wiik; O Orum; N Strandberg Pedersen
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

10.  Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results.

Authors:  S Loizou; J D McCrea; A C Rudge; R Reynolds; C C Boyle; E N Harris
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.